Jinling Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Jinling Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jinling Pharmaceutical Co Ltd (000919) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.01 Million ≈ $10.83 Million USD) by net assets (CN¥4.85 Billion ≈ $709.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jinling Pharmaceutical Co Ltd (1999–2024)
Cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024. This chart illustrates how Jinling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Jinling Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
Jinling Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Jinling Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jinling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jinling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Jinling Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Immix Biopharma Inc
NASDAQ:IMMX
|
-0.051x |
|
Zhejiang Xinneng Photovoltaic Technology Co Ltd
SHG:603105
|
0.082x |
|
Nextool Technology Co. Ltd. A
SHG:688419
|
N/A |
|
Groupe CRIT SA
PA:CEN
|
0.112x |
|
Woori Technology Inc
KQ:032820
|
-0.028x |
|
Northern United Publishing & Media Group Co Ltd
SHG:601999
|
-0.032x |
|
Hebei Sailhero Environmental
SHE:300137
|
0.020x |
|
Anhui Huaheng Biotechnology Co. Ltd. A
SHG:688639
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Jinling Pharmaceutical Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024. Review 000919 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.85 Billion ≈ $709.50 Million |
CN¥154.19 Million ≈ $22.56 Million |
0.032x | -26.26% |
| 2023-12-31 | CN¥3.68 Billion ≈ $539.22 Million |
CN¥158.92 Million ≈ $23.26 Million |
0.043x | -39.97% |
| 2022-12-31 | CN¥3.63 Billion ≈ $530.75 Million |
CN¥260.59 Million ≈ $38.13 Million |
0.072x | -13.04% |
| 2021-12-31 | CN¥3.53 Billion ≈ $517.22 Million |
CN¥292.03 Million ≈ $42.73 Million |
0.083x | -8.93% |
| 2020-12-31 | CN¥3.43 Billion ≈ $502.38 Million |
CN¥311.46 Million ≈ $45.58 Million |
0.091x | -33.30% |
| 2019-12-31 | CN¥3.42 Billion ≈ $501.14 Million |
CN¥465.85 Million ≈ $68.17 Million |
0.136x | +1.78% |
| 2018-12-31 | CN¥3.25 Billion ≈ $475.00 Million |
CN¥433.83 Million ≈ $63.48 Million |
0.134x | -7.89% |
| 2017-12-31 | CN¥3.05 Billion ≈ $446.88 Million |
CN¥443.11 Million ≈ $64.84 Million |
0.145x | +360.72% |
| 2016-12-31 | CN¥3.05 Billion ≈ $446.75 Million |
CN¥96.15 Million ≈ $14.07 Million |
0.031x | -56.65% |
| 2015-12-31 | CN¥2.92 Billion ≈ $427.95 Million |
CN¥212.45 Million ≈ $31.09 Million |
0.073x | -33.36% |
| 2014-12-31 | CN¥2.75 Billion ≈ $402.55 Million |
CN¥299.89 Million ≈ $43.88 Million |
0.109x | +3.48% |
| 2013-12-31 | CN¥2.57 Billion ≈ $376.72 Million |
CN¥271.21 Million ≈ $39.69 Million |
0.105x | +11.91% |
| 2012-12-31 | CN¥2.47 Billion ≈ $360.82 Million |
CN¥232.12 Million ≈ $33.97 Million |
0.094x | +26.66% |
| 2011-12-31 | CN¥2.33 Billion ≈ $340.26 Million |
CN¥172.82 Million ≈ $25.29 Million |
0.074x | -8.07% |
| 2010-12-31 | CN¥2.20 Billion ≈ $321.83 Million |
CN¥177.81 Million ≈ $26.02 Million |
0.081x | -11.82% |
| 2009-12-31 | CN¥2.05 Billion ≈ $300.70 Million |
CN¥188.41 Million ≈ $27.57 Million |
0.092x | -43.58% |
| 2008-12-31 | CN¥1.88 Billion ≈ $274.89 Million |
CN¥305.26 Million ≈ $44.67 Million |
0.162x | +168.31% |
| 2007-12-31 | CN¥1.95 Billion ≈ $285.26 Million |
CN¥118.06 Million ≈ $17.28 Million |
0.061x | -25.72% |
| 2006-12-31 | CN¥1.70 Billion ≈ $248.57 Million |
CN¥138.50 Million ≈ $20.27 Million |
0.082x | +16.56% |
| 2005-12-31 | CN¥1.56 Billion ≈ $228.64 Million |
CN¥109.29 Million ≈ $15.99 Million |
0.070x | -35.69% |
| 2004-12-31 | CN¥1.47 Billion ≈ $214.99 Million |
CN¥159.81 Million ≈ $23.38 Million |
0.109x | -7.32% |
| 2003-12-31 | CN¥1.38 Billion ≈ $201.81 Million |
CN¥161.86 Million ≈ $23.69 Million |
0.117x | +11.72% |
| 2002-12-31 | CN¥1.24 Billion ≈ $181.58 Million |
CN¥130.36 Million ≈ $19.08 Million |
0.105x | +26.04% |
| 2001-12-31 | CN¥1.11 Billion ≈ $162.39 Million |
CN¥92.49 Million ≈ $13.53 Million |
0.083x | -61.78% |
| 2000-12-31 | CN¥1.06 Billion ≈ $155.22 Million |
CN¥231.31 Million ≈ $33.85 Million |
0.218x | +458.19% |
| 1999-12-31 | CN¥1.02 Billion ≈ $148.96 Million |
CN¥39.77 Million ≈ $5.82 Million |
0.039x | -- |
About Jinling Pharmaceutical Co Ltd
Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China and internationally. The company offers Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, multiple arteriosclerosis, phlebitis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, an… Read more